Selected research
Industry Research
Bio Simulation Industry Research Report 2026
Market perspective
The global Bio Simulation market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
North America: the Bio Simulation market is projected to increase from US$ million in 2026 to US$ million by 2032, reflecting a CAGR of % over 2026–2032. Europe: the Bio Simulation market is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032. Asia Pacific: the Bio Simulation market is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032. Leading global service providers of Bio Simulation include Medtronic, Simulations Plus Inc., Schrodinger Inc., Rhenovia Pharma, PPD Inc., Physiomics Plc, Intelligen Inc., Genedata AG and Entelos Holding Corporation, among others; in 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
Read the full market overview
This report quantifies the global Bio Simulation market in terms of revenue (US$ million) and, where applicable, service volume (k units), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region or country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to Bio Simulation.
Key Companies & Market Share Insights
This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Bio Simulation Market by Company
Medtronic
Simulations Plus Inc.
Schrodinger Inc.
Rhenovia Pharma
PPD Inc.
Physiomics Plc
Intelligen Inc.
Genedata AG
Entelos Holding Corporation
Dassault Systemes SE
Chemical Computing Group
Certara LP
ANSYS Inc.
Altair Engineering Inc.
Advanced Chemistry Development
Bio Simulation Segment by Type
Software
Services
Bio Simulation Segment by Application
Pharmaceutical and Biotechnology Companies
Contract Research Organizations
Other End Users
Bio Simulation Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Spain
Russia
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Colombia
Middle East & Africa
Saudi Arabia
Israel
United Arab Emirates
Turkey
Iran
Egypt
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Bio Simulation market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Bio Simulation and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Bio Simulation.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Bio Simulation companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Software
- Services
Applications
- Pharmaceutical and Biotechnology Companies
- Contract Research Organizations
- Other End Users
Companies covered
- Medtronic
- Simulations Plus Inc.
- Schrodinger Inc.
- Rhenovia Pharma
- PPD Inc.
- Physiomics Plc
- Intelligen Inc.
- Genedata AG
- Entelos Holding Corporation
- Dassault Systemes SE
- Chemical Computing Group
- Certara LP
- ANSYS Inc.
- Altair Engineering Inc.
- Advanced Chemistry Development
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Bio Simulation by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
- 2.2.2 Software
- 2.2.3 Services
- 2.3 Bio Simulation by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.3.2 Pharmaceutical and Biotechnology Companies
- 2.3.3 Contract Research Organizations
- 2.3.4 Other End Users
- 2.4 Assumptions and Limitations
3 Bio Simulation Breakdown Data by Type
- 3.1 Global Bio Simulation Historic Market Size by Type (2021-2026)
- 3.2 Global Bio Simulation Forecasted Market Size by Type (2027-2032)
4 Bio Simulation Breakdown Data by Application
- 4.1 Global Bio Simulation Historic Market Size by Application (2021-2026)
- 4.2 Global Bio Simulation Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
- 5.1 Global Bio Simulation Market Perspective (2021-2032)
- 5.2 Global Bio Simulation Growth Trends by Region
- 5.2.1 Global Bio Simulation Market Size by Region: 2021 VS 2025 VS 2032
- 5.2.2 Bio Simulation Historic Market Size by Region (2021-2026)
- 5.2.3 Bio Simulation Forecasted Market Size by Region (2027-2032)
- 5.3 Bio Simulation Market Dynamics
- 5.3.1 Bio Simulation Industry Trends
- 5.3.2 Bio Simulation Market Drivers
- 5.3.3 Bio Simulation Market Challenges
- 5.3.4 Bio Simulation Market Restraints
6 Market Competitive Landscape by Players
- 6.1 Global Top Bio Simulation Players by Revenue
- 6.1.1 Global Top Bio Simulation Players by Revenue (2021-2026)
- 6.1.2 Global Bio Simulation Revenue Market Share by Players (2021-2026)
- 6.2 Global Bio Simulation Industry Players Ranking, 2023 VS 2024 VS 2025
- 6.3 Global Key Players of Bio Simulation Head Office and Area Served
- 6.4 Global Bio Simulation Players, Product Type & Application
- 6.5 Global Bio Simulation Manufacturers Established Date
- 6.6 Global Bio Simulation Market CR5 and HHI
- 6.7 Global Players Mergers & Acquisition
7 North America
- 7.1 North America Bio Simulation Market Size (2021-2032)
- 7.2 North America Bio Simulation Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 7.3 North America Bio Simulation Market Size by Country (2021-2026)
- 7.4 North America Bio Simulation Market Size by Country (2027-2032)
- 7.5 United States
- 7.5 United States
- 7.6 Canada
- 7.7 Mexico
8 Europe
- 8.1 Europe Bio Simulation Market Size (2021-2032)
- 8.2 Europe Bio Simulation Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.3 Europe Bio Simulation Market Size by Country (2021-2026)
- 8.4 Europe Bio Simulation Market Size by Country (2027-2032)
- 8.5 Germany
- 8.6 France
- 8.7 U.K.
- 8.8 Italy
- 8.9 Spain
- 8.10 Russia
- 8.11 Netherlands
- 8.12 Nordic Countries
9 Asia-Pacific
- 9.1 Asia-Pacific Bio Simulation Market Size (2021-2032)
- 9.2 Asia-Pacific Bio Simulation Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 9.3 Asia-Pacific Bio Simulation Market Size by Country (2021-2026)
- 9.4 Asia-Pacific Bio Simulation Market Size by Country (2027-2032)
- 9.5 China
- 9.6 Japan
- 9.7 South Korea
- 9.8 India
- 9.9 Australia
- 9.10 China Taiwan
- 9.11 Southeast Asia
10 South America
- 10.1 South America Bio Simulation Market Size (2021-2032)
- 10.2 South America Bio Simulation Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 10.3 South America Bio Simulation Market Size by Country (2021-2026)
- 10.4 South America Bio Simulation Market Size by Country (2027-2032)
- 10.5 Brazil
- 10.6 Argentina
- 10.7 Chile
- 10.8 Colombia
- 10.9 Peru
11 Middle East & Africa
- 11.1 Middle East & Africa Bio Simulation Market Size (2021-2032)
- 11.2 Middle East & Africa Bio Simulation Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 11.3 Middle East & Africa Bio Simulation Market Size by Country (2021-2026)
- 11.4 Middle East & Africa Bio Simulation Market Size by Country (2027-2032)
- 11.5 Saudi Arabia
- 11.6 Israel
- 11.7 United Arab Emirates
- 11.8 Turkey
- 11.9 Iran
- 11.10 Egypt
12 Players Profiled
- 12.1 Medtronic
- 12.1.1 Medtronic Company Information
- 12.1.2 Medtronic Business Overview
- 12.1.3 Medtronic Revenue in Bio Simulation Business (2021-2026)
- 12.1.4 Medtronic Bio Simulation Product Portfolio
- 12.1.5 Medtronic Recent Developments
- 12.2 Simulations Plus Inc.
- 12.2.1 Simulations Plus Inc. Company Information
- 12.2.2 Simulations Plus Inc. Business Overview
- 12.2.3 Simulations Plus Inc. Revenue in Bio Simulation Business (2021-2026)
- 12.2.4 Simulations Plus Inc. Bio Simulation Product Portfolio
- 12.2.5 Simulations Plus Inc. Recent Developments
- 12.3 Schrodinger Inc.
- 12.3.1 Schrodinger Inc. Company Information
- 12.3.2 Schrodinger Inc. Business Overview
- 12.3.3 Schrodinger Inc. Revenue in Bio Simulation Business (2021-2026)
- 12.3.4 Schrodinger Inc. Bio Simulation Product Portfolio
- 12.3.5 Schrodinger Inc. Recent Developments
- 12.4 Rhenovia Pharma
- 12.4.1 Rhenovia Pharma Company Information
- 12.4.2 Rhenovia Pharma Business Overview
- 12.4.3 Rhenovia Pharma Revenue in Bio Simulation Business (2021-2026)
- 12.4.4 Rhenovia Pharma Bio Simulation Product Portfolio
- 12.4.5 Rhenovia Pharma Recent Developments
- 12.5 PPD Inc.
- 12.5.1 PPD Inc. Company Information
- 12.5.2 PPD Inc. Business Overview
- 12.5.3 PPD Inc. Revenue in Bio Simulation Business (2021-2026)
- 12.5.4 PPD Inc. Bio Simulation Product Portfolio
- 12.5.5 PPD Inc. Recent Developments
- 12.6 Physiomics Plc
- 12.6.1 Physiomics Plc Company Information
- 12.6.2 Physiomics Plc Business Overview
- 12.6.3 Physiomics Plc Revenue in Bio Simulation Business (2021-2026)
- 12.6.4 Physiomics Plc Bio Simulation Product Portfolio
- 12.6.5 Physiomics Plc Recent Developments
- 12.7 Intelligen Inc.
- 12.7.1 Intelligen Inc. Company Information
- 12.7.2 Intelligen Inc. Business Overview
- 12.7.3 Intelligen Inc. Revenue in Bio Simulation Business (2021-2026)
- 12.7.4 Intelligen Inc. Bio Simulation Product Portfolio
- 12.7.5 Intelligen Inc. Recent Developments
- 12.8 Genedata AG
- 12.8.1 Genedata AG Company Information
- 12.8.2 Genedata AG Business Overview
- 12.8.3 Genedata AG Revenue in Bio Simulation Business (2021-2026)
- 12.8.4 Genedata AG Bio Simulation Product Portfolio
- 12.8.5 Genedata AG Recent Developments
- 12.9 Entelos Holding Corporation
- 12.9.1 Entelos Holding Corporation Company Information
- 12.9.2 Entelos Holding Corporation Business Overview
- 12.9.3 Entelos Holding Corporation Revenue in Bio Simulation Business (2021-2026)
- 12.9.4 Entelos Holding Corporation Bio Simulation Product Portfolio
- 12.9.5 Entelos Holding Corporation Recent Developments
- 12.10 Dassault Systemes SE
- 12.10.1 Dassault Systemes SE Company Information
- 12.10.2 Dassault Systemes SE Business Overview
- 12.10.3 Dassault Systemes SE Revenue in Bio Simulation Business (2021-2026)
- 12.10.4 Dassault Systemes SE Bio Simulation Product Portfolio
- 12.10.5 Dassault Systemes SE Recent Developments
- 12.11 Chemical Computing Group
- 12.11.1 Chemical Computing Group Company Information
- 12.11.2 Chemical Computing Group Business Overview
- 12.11.3 Chemical Computing Group Revenue in Bio Simulation Business (2021-2026)
- 12.11.4 Chemical Computing Group Bio Simulation Product Portfolio
- 12.11.5 Chemical Computing Group Recent Developments
- 12.12 Certara LP
- 12.12.1 Certara LP Company Information
- 12.12.2 Certara LP Business Overview
- 12.12.3 Certara LP Revenue in Bio Simulation Business (2021-2026)
- 12.12.4 Certara LP Bio Simulation Product Portfolio
- 12.12.5 Certara LP Recent Developments
- 12.13 ANSYS Inc.
- 12.13.1 ANSYS Inc. Company Information
- 12.13.2 ANSYS Inc. Business Overview
- 12.13.3 ANSYS Inc. Revenue in Bio Simulation Business (2021-2026)
- 12.13.4 ANSYS Inc. Bio Simulation Product Portfolio
- 12.13.5 ANSYS Inc. Recent Developments
- 12.14 Altair Engineering Inc.
- 12.14.1 Altair Engineering Inc. Company Information
- 12.14.2 Altair Engineering Inc. Business Overview
- 12.14.3 Altair Engineering Inc. Revenue in Bio Simulation Business (2021-2026)
- 12.14.4 Altair Engineering Inc. Bio Simulation Product Portfolio
- 12.14.5 Altair Engineering Inc. Recent Developments
- 12.15 Advanced Chemistry Development
- 12.15.1 Advanced Chemistry Development Company Information
- 12.15.2 Advanced Chemistry Development Business Overview
- 12.15.3 Advanced Chemistry Development Revenue in Bio Simulation Business (2021-2026)
- 12.15.4 Advanced Chemistry Development Bio Simulation Product Portfolio
- 12.15.5 Advanced Chemistry Development Recent Developments
13 Report Conclusion
14 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst